DRP-104 can promote apoptosis of tumor cells, and activate innate and adaptive immune response in vivo , such as inducing polarization of TAM to M1 phenotype, reducing T cell depletion, and increasing NK cells (Yokoyama et al., 2022)
Patient and public involvement This experiment was designed, carried out, analyzed, and reported without any official involvement from patients or the general public
25 To obtain more accurate epidemiological data on cancer cachexia, we incorporated dozens of additional studies published in the past five years, 19,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45 which provide comprehensive information for the 14 selected cancer entities analyzed (liver cancer, pancreatic cancer, gastric cancer, esophageal cancer, esophagogastric cancer, colorectal cancer, lung cancer, thyroid cancer, head and neck cancer, gynecological tumors, urogenital cancer, hematologic malignancies, breast cancer, melanoma and others) (Fig
Anti-inflammatory effects A study by lee et al., reported that after LC administration, patients in the L-carnitine group demonstrated significantly lower levels of inflammatory markers including C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-) compared to both baseline values and the placebo group
